# Prospective Study of Rapamycin for the Treatment of SLE

> **NCT00779194** · PHASE2 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 99 (actual)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **DRUG:** Rapamycin

## Key facts

- **NCT ID:** NCT00779194
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12-16
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2024-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00779194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00779194, "Prospective Study of Rapamycin for the Treatment of SLE". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00779194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*